Who does this study affect? People with castration-resistant metastatic prostate cancer (mCRPC) with or without homologous recombination repair (HRR) gene alterations. What did this study find? The ...

Confirm that they can objectively measure the tumor by physical or radiographic exam per RECIST v1.1. Review the patient’s molecular test from a CLIA-certified and CAP-accredited or New York ...

Cerebrospinal fluid immunological cytokines to predict intracranial tumor response to immunotherapy in non-small cell lung cancer patients with brain metastases: GASTO 1060. Effect of a novel ...

The Association for Clinical Oncology (ASCO) has signed on to a joint letter to Congressional leaders about the impact of potential Medicaid cuts on access to cancer care for children. Led by the ...

On February 26, the House Energy & Commerce Health Subcommittee held a hearing to address the impact of pharmacy benefit managers (PBMs) on the cost of health care. The Association for Clinical ...

The American Society of Clinical Oncology (ASCO) and the American Cancer Society (ACS) are hosting a webinar to help oncology professionals gain actionable strategies for implementing sustainable ...

The Association for Clinical Oncology (ASCO) is one of nearly 50 specialty groups urging the National Institutes of Health (NIH) to rescind a recent policy change limiting how much research ...

On March 10, the Centers for Medicare & Medicaid Services (CMS) released the Marketplace Integrity and Affordability Proposed Rule aimed at addressing improper enrollments in the Affordable Care Act ...

On January 1, 2025, a 2.8% cut to Medicare physician reimbursement went into effect. The cut followed a 1.68% cut from 2024, while the cost of running a medical practice continues to rise due to ...

The deadline for Congress to pass a spending bill to fund the federal government—including the National Institutes of Health (NIH), National Cancer Institute (NCI), the Advanced Research Projects ...